Ding Haojie, Wu Songrui, Jin Zi, Zheng Bin, Hu Yuan, He Ke, Lu Shaohong, Zhuo Xunhui
School of Basic Medical Sciences and Forensic Medicine, Hangzhou Medical College, Hangzhou 310059, China.
Key Laboratory of Parasite and Vector Biology, National Health Commission of People's Republic of China, National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention (Chinese Center for Tropical Diseases Research), WHO Collaborating Center for Tropical Diseases, Shanghai 200025, China.
Bioengineering (Basel). 2022 Aug 16;9(8):395. doi: 10.3390/bioengineering9080395.
The immune system may aberrantly silence when against "altered self", which consequently may develop into malignancies. With the development of tumor immunology and molecular biology, the deepened understanding of the relationship between parasites and tumors shifts the attitude towards parasitic pathogens from elimination to utilization. In recent years, the antitumor impact implemented by protozoan parasites and the derived products has been confirmed. The immune system is activated and enhanced by some protozoan parasites, thereby inhibiting tumor growth, angiogenesis, and metastasis in many animal models. In this work, we reviewed the available information on the antitumor effect of parasitic infection or induced by parasitic antigen, as well as the involved immune mechanisms that modulate cancer progression. Despite the fact that clinical trials of the protozoan parasites against tumors are limited and the specific mechanisms of the effect on tumors are not totally clear, the use of genetically modified protozoan parasites and derived molecules combined with chemotherapy could be an important element for promoting antitumor treatment in the future.
免疫系统在对抗“自身改变”时可能会异常沉默,这可能进而发展为恶性肿瘤。随着肿瘤免疫学和分子生物学的发展,对寄生虫与肿瘤之间关系的深入理解,使得对寄生性病原体的态度从消除转变为利用。近年来,原生动物寄生虫及其衍生产品所产生的抗肿瘤作用已得到证实。一些原生动物寄生虫可激活并增强免疫系统,从而在许多动物模型中抑制肿瘤生长、血管生成和转移。在这项工作中,我们综述了关于寄生虫感染或寄生虫抗原诱导的抗肿瘤作用的现有信息,以及调节癌症进展的相关免疫机制。尽管原生动物寄生虫用于肿瘤治疗的临床试验有限,且其对肿瘤作用的具体机制尚不完全清楚,但使用基因改造的原生动物寄生虫及其衍生分子联合化疗可能是未来促进抗肿瘤治疗的一个重要因素。